Pathogenesis, Immune Response and Vaccine Development in Amoebiasis
DOI:
https://doi.org/10.37591/rrjoi.v5i3.1266Abstract
Worldwide, approximately fifty million cases of invasive E histolytica disease occur each year and resulting in more than 100,000 deaths. It is the second leading cause of mortality due to a protozoan parasitic infection after malaria. Entamoeba histolytica infection is associated with considerable morbidity and mortality in the form of intestinal and extra-intestinal amoebiasis especially in developing countries. Recent molecular studies have conclusively proved that there are morphologically similar species of Entamoeba. Of these, Entamoeba histolytica is pathogenic and invasive, where as E. dispar and E. moshkovskii are non-pathogenic and non-invasive. There is a degree of controversy about pathogenic potential of E. dispar and E. moshkovskii. The extraordinary phagocytic activity of Entamoeba histolytica trophozoites has been accepted as one of the virulence mechanisms responsible for their invasive capacity. The genetic, environmental and nutritional factors may influence the host susceptibility to amoebiasis. The parasite has a number of virulence factors and evasive mechanisms to counter immunity of host. Trophozoites secrete proteases enzymes to degrade extracellular matrix to invade the intestinal layers. A safe and effective vaccine for amoebiasis could drastically reduce morbidity and mortality. Studies indicate vaccines directed against Gal-lectin as the most promising and effective. Immunity that generates a strong intestinal humoral antibody IgA response would prevent the parasite colonization and subsequent intestinal invasion. Immunity to reinfection caused by heterologous species would be a challenge in vaccine production. Although some of the vaccines are tested in animal models, there is a need for clinical trials to prove its efficiency in humans. At present, in the absence of safe and effective vaccine, other control and prevention measures take prime spot.
Keywords: Entamoeba histolytica, amoebiasis, amoebic liver abscess, immunity, dysentery, immune response, vaccine, pathogenesis, Entamoeba dispar, Gal-lectin
Cite this Article
Durgadas Govind Naik. Pathogenesis, immune response and vaccine development in amoebiasis. Research and Reviews: Journal of Immunology. 2015; 5(3): 30–35p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
